GlassScriptPhysician profile
Mychi H Le
NPI 1952539660
$5,118.34
in general payments reported to CMS, 2019-2025
38 companies · $2,171 in 2025
The $2,171 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $194 · 2021: $149 · 2022: $12.33 · 2023: $592 · 2024: $1,385 · 2025: $2,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,601 · Travel and Lodging: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,600.75 |
| Travel and Lodging | $547.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $872.77 | 2025 | |
| Incyte Corporation | $510.56 | 2023-2025 | Opzelura |
| Lilly USA, LLC | $430.63 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Ucb, INC. | $336.98 | 2019-2025 | Bimzelx |
| Mentor Worldwide LLC | $298.39 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Janssen Biotech, INC. | $291.46 | 2021-2025 | Tremfya |
| Endo Pharmaceuticals INC. | $228.89 | 2019-2024 | Xiaflex |
| Allergan, INC. | $209.44 | 2019-2020 | |
| Leo Pharma INC. | $182.62 | 2019-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $150.12 | 2024-2025 | Libtayo, Dupixent |
| Avita Medical Americas, LLC | $149.93 | 2025 | Recell |
| Arcutis Biotherapeutics, INC. | $137.40 | 2024 | Zoryve |
| Abbvie INC. | $128.20 | 2023-2024 | |
| Sientra, INC. | $112.10 | 2020-2021 | |
| Pfizer INC. | $111.73 | 2023 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $110.42 | 2023 | |
| Amgen INC. | $99.67 | 2019-2025 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $96.11 | 2025 | Sotyktu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.55 | 2023-2025 | Spevigo, Cyltezo |
| Dermavant Sciences, INC. | $69.88 | 2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $65.80 | 2025 | |
| Genzyme Corporation | $48.48 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $43.11 | 2025 | Acthar |
| Integra Lifesciences Corporation | $38.64 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Verrica Pharmaceuticals INC. | $35.81 | 2023-2024 | Ycanth |
| Mayne Pharma Commercial LLC | $34.69 | 2025 | |
| Genentech USA, INC. | $29.74 | 2024 | Erivedge |
| Kci USA, INC. | $28.52 | 2019 | |
| Motiva USA, LLC | $24.73 | 2025 | |
| Baxter Healthcare | $24.46 | 2019 | |
| Almirall LLC | $22.55 | 2024 | Seysara |
| Kerecis Limited | $20.41 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Journey Medical Corporation | $16.52 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.12 | 2024 | Cabtreo |
| Kyowa Kirin, INC. | $12.71 | 2020 | |
| Galderma Laboratories, L.P. | $11.73 | 2019 | |
| Organon LLC | $11.31 | 2024 | |
| Biofrontera INC. | $11.16 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mychi Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.